nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—CHRM3—muscle of abdomen—ovarian cancer	0.104	0.201	CbGeAlD
Promazine—HTR2A—vein—ovarian cancer	0.0474	0.0919	CbGeAlD
Promazine—DRD4—testis—ovarian cancer	0.0224	0.0434	CbGeAlD
Promazine—CHRM5—epithelium—ovarian cancer	0.0221	0.0428	CbGeAlD
Promazine—ADRA1D—epithelium—ovarian cancer	0.0197	0.0382	CbGeAlD
Promazine—CHRM4—testis—ovarian cancer	0.0169	0.0328	CbGeAlD
Promazine—ADRA1D—female reproductive system—ovarian cancer	0.0146	0.0284	CbGeAlD
Promazine—ADRA1A—epithelium—ovarian cancer	0.0113	0.022	CbGeAlD
Promazine—HRH1—myometrium—ovarian cancer	0.0112	0.0217	CbGeAlD
Promazine—ADRA2A—myometrium—ovarian cancer	0.011	0.0213	CbGeAlD
Promazine—HTR2C—female reproductive system—ovarian cancer	0.0108	0.021	CbGeAlD
Promazine—CHRM1—female reproductive system—ovarian cancer	0.0102	0.0199	CbGeAlD
Promazine—CHRM3—female reproductive system—ovarian cancer	0.00916	0.0178	CbGeAlD
Promazine—HTR2A—embryo—ovarian cancer	0.00897	0.0174	CbGeAlD
Promazine—HRH1—epithelium—ovarian cancer	0.00877	0.017	CbGeAlD
Promazine—HRH1—uterine cervix—ovarian cancer	0.00869	0.0169	CbGeAlD
Promazine—ADRA2A—uterine cervix—ovarian cancer	0.00854	0.0166	CbGeAlD
Promazine—CHRM3—female gonad—ovarian cancer	0.00834	0.0162	CbGeAlD
Promazine—HRH1—decidua—ovarian cancer	0.00828	0.0161	CbGeAlD
Promazine—ADRA2A—decidua—ovarian cancer	0.00813	0.0158	CbGeAlD
Promazine—HRH1—endometrium—ovarian cancer	0.00786	0.0152	CbGeAlD
Promazine—ADRA2A—endometrium—ovarian cancer	0.00772	0.015	CbGeAlD
Promazine—CYP2C19—vagina—ovarian cancer	0.0077	0.0149	CbGeAlD
Promazine—CHRM3—testis—ovarian cancer	0.0074	0.0143	CbGeAlD
Promazine—HTR2A—epithelium—ovarian cancer	0.00732	0.0142	CbGeAlD
Promazine—ADRA2A—gonad—ovarian cancer	0.00716	0.0139	CbGeAlD
Promazine—ADRA2A—uterus—ovarian cancer	0.00712	0.0138	CbGeAlD
Promazine—DRD2—testis—ovarian cancer	0.00666	0.0129	CbGeAlD
Promazine—CYP2C9—female reproductive system—ovarian cancer	0.0066	0.0128	CbGeAlD
Promazine—HRH1—female reproductive system—ovarian cancer	0.00651	0.0126	CbGeAlD
Promazine—ADRA2A—female reproductive system—ovarian cancer	0.0064	0.0124	CbGeAlD
Promazine—HTR2A—gonad—ovarian cancer	0.00609	0.0118	CbGeAlD
Promazine—HRH1—female gonad—ovarian cancer	0.00593	0.0115	CbGeAlD
Promazine—HRH1—vagina—ovarian cancer	0.00589	0.0114	CbGeAlD
Promazine—ADRA2A—female gonad—ovarian cancer	0.00582	0.0113	CbGeAlD
Promazine—ADRA2A—vagina—ovarian cancer	0.00579	0.0112	CbGeAlD
Promazine—HTR2A—female reproductive system—ovarian cancer	0.00544	0.0105	CbGeAlD
Promazine—HRH1—testis—ovarian cancer	0.00526	0.0102	CbGeAlD
Promazine—ADRA2A—testis—ovarian cancer	0.00516	0.01	CbGeAlD
Promazine—CYP3A4—female reproductive system—ovarian cancer	0.00504	0.00976	CbGeAlD
Promazine—HTR2A—vagina—ovarian cancer	0.00492	0.00954	CbGeAlD
Promazine—Tamoxifen—CYP1B1—ovarian cancer	0.00442	0.149	CrCbGaD
Promazine—HTR2A—testis—ovarian cancer	0.00439	0.00851	CbGeAlD
Promazine—HRH1—lymph node—ovarian cancer	0.00381	0.00739	CbGeAlD
Promazine—ADRA2A—lymph node—ovarian cancer	0.00374	0.00725	CbGeAlD
Promazine—Tamoxifen—ESR1—ovarian cancer	0.00299	0.101	CrCbGaD
Promazine—Diltiazem—ABCB1—ovarian cancer	0.0023	0.0776	CrCbGaD
Promazine—Triflupromazine—ABCB1—ovarian cancer	0.00205	0.0691	CrCbGaD
Promazine—Carbamazepine—ABCB1—ovarian cancer	0.00171	0.0577	CrCbGaD
Promazine—Fluphenazine—ABCB1—ovarian cancer	0.00158	0.0532	CrCbGaD
Promazine—Clomipramine—ABCB1—ovarian cancer	0.00144	0.0486	CrCbGaD
Promazine—Chlorprothixene—ABCB1—ovarian cancer	0.00144	0.0484	CrCbGaD
Promazine—Trimipramine—ABCB1—ovarian cancer	0.00133	0.0447	CrCbGaD
Promazine—Promethazine—ABCB1—ovarian cancer	0.00128	0.0431	CrCbGaD
Promazine—Tamoxifen—ABCB1—ovarian cancer	0.00127	0.0428	CrCbGaD
Promazine—Doxepin—ABCB1—ovarian cancer	0.00126	0.0426	CrCbGaD
Promazine—Trifluoperazine—ABCB1—ovarian cancer	0.00126	0.0425	CrCbGaD
Promazine—Quetiapine—ABCB1—ovarian cancer	0.00122	0.0412	CrCbGaD
Promazine—Desipramine—ABCB1—ovarian cancer	0.00116	0.0391	CrCbGaD
Promazine—Chlorpromazine—ABCB1—ovarian cancer	0.000989	0.0333	CrCbGaD
Promazine—Imipramine—ABCB1—ovarian cancer	0.000984	0.0332	CrCbGaD
Promazine—Amitriptyline—ABCB1—ovarian cancer	0.000978	0.033	CrCbGaD
Promazine—HRH1—Signaling by GPCR—IL6—ovarian cancer	5.13e-05	0.000113	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—PIK3CA—ovarian cancer	5.13e-05	0.000113	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—AKT1—ovarian cancer	5.13e-05	0.000113	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL2—ovarian cancer	5.12e-05	0.000113	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CCND1—ovarian cancer	5.12e-05	0.000113	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MTOR—ovarian cancer	5.12e-05	0.000113	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PIK3CB—ovarian cancer	5.12e-05	0.000113	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—AKT1—ovarian cancer	5.12e-05	0.000113	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—IL6—ovarian cancer	5.11e-05	0.000113	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—IL6—ovarian cancer	5.1e-05	0.000112	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5.09e-05	0.000112	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CASP3—ovarian cancer	5.08e-05	0.000112	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL2—ovarian cancer	5.07e-05	0.000112	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CTNNB1—ovarian cancer	5.07e-05	0.000112	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CASP3—ovarian cancer	5.07e-05	0.000111	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—PIK3CA—ovarian cancer	5.06e-05	0.000111	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL2—ovarian cancer	5.06e-05	0.000111	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—VEGFA—ovarian cancer	5.06e-05	0.000111	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—IL6—ovarian cancer	5.05e-05	0.000111	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CCND1—ovarian cancer	5.04e-05	0.000111	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—IL6—ovarian cancer	5.03e-05	0.000111	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CCND1—ovarian cancer	5.03e-05	0.000111	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—KRAS—ovarian cancer	5.03e-05	0.000111	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CCND1—ovarian cancer	5.01e-05	0.00011	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—STAT3—ovarian cancer	5.01e-05	0.00011	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—NRAS—ovarian cancer	5e-05	0.00011	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CCND1—ovarian cancer	5e-05	0.00011	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CTNNB1—ovarian cancer	4.99e-05	0.00011	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CTNNB1—ovarian cancer	4.98e-05	0.00011	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	4.98e-05	0.000109	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MMP9—ovarian cancer	4.97e-05	0.000109	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CTNNB1—ovarian cancer	4.96e-05	0.000109	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—TP53—ovarian cancer	4.96e-05	0.000109	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—KRAS—ovarian cancer	4.96e-05	0.000109	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CCND1—ovarian cancer	4.95e-05	0.000109	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CTNNB1—ovarian cancer	4.95e-05	0.000109	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—PTEN—ovarian cancer	4.94e-05	0.000109	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CCND1—ovarian cancer	4.93e-05	0.000109	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CXCL8—ovarian cancer	4.92e-05	0.000108	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CTNNB1—ovarian cancer	4.9e-05	0.000108	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TP53—ovarian cancer	4.9e-05	0.000108	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MMP9—ovarian cancer	4.89e-05	0.000108	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—HRAS—ovarian cancer	4.89e-05	0.000108	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CTNNB1—ovarian cancer	4.89e-05	0.000107	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MMP9—ovarian cancer	4.88e-05	0.000107	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MMP9—ovarian cancer	4.86e-05	0.000107	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PTEN—ovarian cancer	4.86e-05	0.000107	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PTEN—ovarian cancer	4.85e-05	0.000107	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MMP9—ovarian cancer	4.85e-05	0.000107	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—PIK3CA—ovarian cancer	4.85e-05	0.000107	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CAV1—ovarian cancer	4.84e-05	0.000107	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—VEGFA—ovarian cancer	4.84e-05	0.000107	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PTEN—ovarian cancer	4.84e-05	0.000106	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—AKT1—ovarian cancer	4.82e-05	0.000106	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PTEN—ovarian cancer	4.82e-05	0.000106	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	4.8e-05	0.000106	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MMP9—ovarian cancer	4.8e-05	0.000106	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—STAT3—ovarian cancer	4.79e-05	0.000105	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	4.79e-05	0.000105	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MAPK3—ovarian cancer	4.78e-05	0.000105	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—NRAS—ovarian cancer	4.78e-05	0.000105	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PTEN—ovarian cancer	4.77e-05	0.000105	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	4.76e-05	0.000105	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	4.75e-05	0.000105	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—HRAS—ovarian cancer	4.75e-05	0.000104	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	4.74e-05	0.000104	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—AKT1—ovarian cancer	4.73e-05	0.000104	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.72e-05	0.000104	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—AKT1—ovarian cancer	4.72e-05	0.000104	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	4.71e-05	0.000104	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—AKT1—ovarian cancer	4.7e-05	0.000103	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL2—ovarian cancer	4.7e-05	0.000103	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TP53—ovarian cancer	4.69e-05	0.000103	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—HRAS—ovarian cancer	4.68e-05	0.000103	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	4.68e-05	0.000103	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	4.66e-05	0.000102	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MYC—ovarian cancer	4.65e-05	0.000102	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	4.64e-05	0.000102	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—TYMS—ovarian cancer	4.64e-05	0.000102	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.63e-05	0.000102	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—PIK3CA—ovarian cancer	4.62e-05	0.000102	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	4.58e-05	0.000101	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MAPK3—ovarian cancer	4.58e-05	0.000101	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—PIK3CA—ovarian cancer	4.56e-05	0.0001	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	4.55e-05	0.0001	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—EGFR—ovarian cancer	4.55e-05	0.0001	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—IL6—ovarian cancer	4.54e-05	9.99e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	4.54e-05	9.99e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.54e-05	9.98e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—HRAS—ovarian cancer	4.48e-05	9.86e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—IL6—ovarian cancer	4.48e-05	9.86e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TP53—ovarian cancer	4.47e-05	9.83e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—VEGFA—ovarian cancer	4.46e-05	9.82e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MYC—ovarian cancer	4.45e-05	9.8e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	4.45e-05	9.79e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	4.42e-05	9.73e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—STAT3—ovarian cancer	4.42e-05	9.72e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4.41e-05	9.7e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—NRAS—ovarian cancer	4.41e-05	9.7e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TP53—ovarian cancer	4.41e-05	9.7e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	4.39e-05	9.66e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—VEGFA—ovarian cancer	4.38e-05	9.64e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—VEGFA—ovarian cancer	4.37e-05	9.61e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MAPK1—ovarian cancer	4.36e-05	9.59e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—EGFR—ovarian cancer	4.36e-05	9.59e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—VEGFA—ovarian cancer	4.35e-05	9.58e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—STAT3—ovarian cancer	4.35e-05	9.57e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—STAT3—ovarian cancer	4.34e-05	9.55e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—NRAS—ovarian cancer	4.34e-05	9.54e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.34e-05	9.54e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—NRAS—ovarian cancer	4.33e-05	9.52e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—STAT3—ovarian cancer	4.33e-05	9.52e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	4.32e-05	9.5e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—NRAS—ovarian cancer	4.32e-05	9.49e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	4.31e-05	9.49e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—STAT3—ovarian cancer	4.31e-05	9.49e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—NRAS—ovarian cancer	4.3e-05	9.46e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	4.3e-05	9.46e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—KRAS—ovarian cancer	4.3e-05	9.46e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—IL6—ovarian cancer	4.29e-05	9.44e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—HRAS—ovarian cancer	4.27e-05	9.4e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—STAT3—ovarian cancer	4.27e-05	9.39e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—NRAS—ovarian cancer	4.26e-05	9.37e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	4.26e-05	9.37e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	4.25e-05	9.35e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	4.22e-05	9.29e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—HRAS—ovarian cancer	4.22e-05	9.27e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—AKT1—ovarian cancer	4.19e-05	9.22e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	4.15e-05	9.14e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MAPK3—ovarian cancer	4.15e-05	9.12e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—AKT1—ovarian cancer	4.13e-05	9.09e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	4.13e-05	9.09e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MAPK3—ovarian cancer	4.12e-05	9.06e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—KRAS—ovarian cancer	4.12e-05	9.06e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MYC—ovarian cancer	4.11e-05	9.04e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—IL6—ovarian cancer	4.09e-05	9e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	4.08e-05	8.97e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	4.07e-05	8.95e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—PIK3CA—ovarian cancer	4.07e-05	8.95e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MYC—ovarian cancer	4.04e-05	8.89e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—IL6—ovarian cancer	4.03e-05	8.88e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MYC—ovarian cancer	4.03e-05	8.87e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MYC—ovarian cancer	4.02e-05	8.84e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	4.02e-05	8.84e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EGFR—ovarian cancer	4.02e-05	8.84e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MYC—ovarian cancer	4.01e-05	8.81e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	4e-05	8.79e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MYC—ovarian cancer	3.97e-05	8.73e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—AKT1—ovarian cancer	3.96e-05	8.71e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MYC—ovarian cancer	3.96e-05	8.71e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	3.96e-05	8.7e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.96e-05	8.7e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	3.95e-05	8.7e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EGFR—ovarian cancer	3.95e-05	8.7e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	3.95e-05	8.69e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	3.95e-05	8.68e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MAPK1—ovarian cancer	3.94e-05	8.68e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EGFR—ovarian cancer	3.94e-05	8.68e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	3.93e-05	8.65e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EGFR—ovarian cancer	3.93e-05	8.65e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MAPK1—ovarian cancer	3.92e-05	8.62e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EGFR—ovarian cancer	3.92e-05	8.62e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	3.88e-05	8.54e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EGFR—ovarian cancer	3.88e-05	8.54e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	3.88e-05	8.53e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	3.87e-05	8.52e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	3.87e-05	8.51e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TP53—ovarian cancer	3.82e-05	8.41e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—KRAS—ovarian cancer	3.79e-05	8.35e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—PIK3CA—ovarian cancer	3.78e-05	8.32e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	3.78e-05	8.32e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—AKT1—ovarian cancer	3.77e-05	8.3e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTEN—ovarian cancer	3.75e-05	8.25e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CAV1—ovarian cancer	3.74e-05	8.22e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—KRAS—ovarian cancer	3.73e-05	8.21e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—PIK3CA—ovarian cancer	3.73e-05	8.21e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—KRAS—ovarian cancer	3.73e-05	8.2e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—AKT1—ovarian cancer	3.72e-05	8.19e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—KRAS—ovarian cancer	3.71e-05	8.17e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—KRAS—ovarian cancer	3.7e-05	8.14e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MYC—ovarian cancer	3.68e-05	8.09e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—KRAS—ovarian cancer	3.67e-05	8.07e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TP53—ovarian cancer	3.66e-05	8.05e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	3.66e-05	8.04e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—HRAS—ovarian cancer	3.65e-05	8.04e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	3.6e-05	7.91e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	3.6e-05	7.91e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—HRAS—ovarian cancer	3.5e-05	7.7e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL6—ovarian cancer	3.5e-05	7.7e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	3.49e-05	7.67e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	3.43e-05	7.55e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	3.42e-05	7.53e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTEN—ovarian cancer	3.42e-05	7.52e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	3.41e-05	7.51e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.4e-05	7.49e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PIK3CA—ovarian cancer	3.4e-05	7.48e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	3.4e-05	7.47e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.38e-05	7.44e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TP53—ovarian cancer	3.37e-05	7.42e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	3.37e-05	7.41e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	3.36e-05	7.39e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL6—ovarian cancer	3.35e-05	7.37e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—AKT1—ovarian cancer	3.32e-05	7.31e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TP53—ovarian cancer	3.32e-05	7.3e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TP53—ovarian cancer	3.31e-05	7.29e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TP53—ovarian cancer	3.3e-05	7.26e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TP53—ovarian cancer	3.29e-05	7.24e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TP53—ovarian cancer	3.26e-05	7.17e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TP53—ovarian cancer	3.25e-05	7.15e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—AKT1—ovarian cancer	3.23e-05	7.1e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—HRAS—ovarian cancer	3.23e-05	7.1e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—HRAS—ovarian cancer	3.17e-05	6.98e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—HRAS—ovarian cancer	3.17e-05	6.97e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—HRAS—ovarian cancer	3.16e-05	6.95e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—HRAS—ovarian cancer	3.15e-05	6.92e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	3.12e-05	6.87e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—HRAS—ovarian cancer	3.12e-05	6.86e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	3.11e-05	6.84e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—AKT1—ovarian cancer	3.09e-05	6.8e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL6—ovarian cancer	3.09e-05	6.79e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—AKT1—ovarian cancer	3.05e-05	6.71e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL6—ovarian cancer	3.04e-05	6.68e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL6—ovarian cancer	3.03e-05	6.67e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL6—ovarian cancer	3.02e-05	6.65e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TP53—ovarian cancer	3.02e-05	6.64e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL6—ovarian cancer	3.01e-05	6.63e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.99e-05	6.58e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL6—ovarian cancer	2.98e-05	6.56e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL6—ovarian cancer	2.97e-05	6.54e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTEN—ovarian cancer	2.92e-05	6.43e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	2.89e-05	6.35e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—AKT1—ovarian cancer	2.85e-05	6.27e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—AKT1—ovarian cancer	2.8e-05	6.17e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—AKT1—ovarian cancer	2.8e-05	6.15e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—AKT1—ovarian cancer	2.79e-05	6.13e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—AKT1—ovarian cancer	2.78e-05	6.11e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL6—ovarian cancer	2.76e-05	6.08e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—AKT1—ovarian cancer	2.75e-05	6.05e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	2.74e-05	6.04e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.64e-05	5.82e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.61e-05	5.74e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	2.55e-05	5.61e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.41e-05	5.3e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTEN—ovarian cancer	2.25e-05	4.96e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—AKT1—ovarian cancer	2.16e-05	4.75e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.06e-05	4.53e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—AKT1—ovarian cancer	1.97e-05	4.33e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—AKT1—ovarian cancer	1.68e-05	3.7e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.59e-05	3.5e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—AKT1—ovarian cancer	1.3e-05	2.86e-05	CbGpPWpGaD
